FORDYCE MARSHALL (President and CEO) sold 16.9% of their position (17.50K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $753.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
+3.77K
Price / share
$2.90
Trade value
$10.93K
% of position
Class A Common Stock
Shares
−3.77K
Price / share
$41.33
Trade value
$155.88K
% of position
Class A Common Stock
Shares
+2.19K
Price / share
$2.90
Trade value
$6.36K
% of position
Class A Common Stock
Shares
−2.19K
Price / share
$42.35
Trade value
$92.95K
% of position
Class A Common Stock
Shares
+5.02K
Price / share
$2.90
Trade value
$14.55K
% of position
Class A Common Stock
Shares
−5.02K
Price / share
$43.52
Trade value
$218.61K
% of position
Class A Common Stock
Shares
+4.63K
Price / share
$2.90
Trade value
$13.43K
% of position
Class A Common Stock
Shares
−4.63K
Price / share
$44.03
Trade value
$204.09K
% of position
Class A Common Stock
Shares
+1.88K
Price / share
$2.90
Trade value
$5.43K
% of position
Class A Common Stock
Shares
−1.88K
Price / share
$43.81
Trade value
$82.14K
% of position
Class A Common Stock
Shares
+57.66K
Price / share
$2.90
Trade value
$167.03K
% of position
Net shares
+57.66K
Net value
-$535.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/18/2024 | M · Option Exercise | +3.77K | $2.90 | $10.93K | 4.4% | 85.94K | 89.71K |
| Class A Common Stock Direct | 12/18/2024 | S · Sale | −3.77K | $41.33 | $155.88K | 4.2% | 89.71K | 85.94K |
| Class A Common Stock Direct | 12/18/2024 | M · Option Exercise | +2.19K | $2.90 | $6.36K | 2.6% | 85.94K | 88.14K |
| Class A Common Stock Direct | 12/18/2024 | S · Sale | −2.19K | $42.35 | $92.95K | 2.5% | 88.14K | 85.94K |
| Class A Common Stock Direct | 12/18/2024 | M · Option Exercise | +5.02K | $2.90 | $14.55K | 5.8% | 85.94K | 90.97K |
| Class A Common Stock Direct | 12/18/2024 | S · Sale | −5.02K | $43.52 | $218.61K | 5.5% | 90.97K | 85.94K |
| Class A Common Stock Direct | 12/18/2024 | M · Option Exercise | +4.63K | $2.90 | $13.43K | 5.4% | 85.94K | 90.58K |
| Class A Common Stock Direct | 12/18/2024 | S · Sale | −4.63K | $44.03 | $204.09K | 5.1% | 90.58K | 85.94K |
| Class A Common Stock Direct | 12/18/2024 | M · Option Exercise | +1.88K | $2.90 | $5.43K | 2.2% | 85.94K | 87.82K |
| Class A Common Stock Direct | 12/18/2024 | S · Sale | −1.88K | $43.81 | $82.14K | 2.1% | 87.82K | 85.94K |
| Class A Common Stock Direct | 12/19/2024 | M · Option Exercise | +57.66K | $2.90 | $167.03K | 67.1% | 85.94K | 143.60K |
| Total | +57.66K | -$535.95K | ||||||
Stock Option (Right to Buy)
Class A Common Stock
15.63K shares
Shares
−15.63K
Strike price
2.8968
Held after
686.09K
Exercisable
—
Stock Option (Right to Buy)
Class A Common Stock
1.88K shares
Shares
−1.88K
Strike price
2.8968
Held after
684.21K
Exercisable
—
Stock Option (Right to Buy)
Class A Common Stock
57.66K shares
Shares
−57.66K
Strike price
2.8968
Held after
626.55K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock15.63K shares | 12/18/2024 | M · Option Exercise | −15.63K | 2.8968 | — | 686.09K |
| Stock Option (Right to Buy) Direct | Class A Common Stock1.88K shares | 12/18/2024 | M · Option Exercise | −1.88K | 2.8968 | — | 684.21K |
| Stock Option (Right to Buy) Direct | Class A Common Stock57.66K shares | 12/19/2024 | M · Option Exercise | −57.66K | 2.8968 | — | 626.55K |
Class A Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 222.03K | Indirect |
| Total | 222.03K | 222.03K indirect |